Article Text

Download PDFPDF

P39 The role of ebus-tbna in isolated intrathoracic lymphadenopathy in non-neoplasic patients – a common dilemma in clinical practice
Free
  1. LM Santos1,
  2. M Jacomelli2,
  3. SE Demarzo2,
  4. VR Figueiredo2
  1. 1Pneumology Unit, Hospitais da Universidade de Coimbra, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal
  2. 2Respiratory Endoscopy Service, Pulmonary Division of Heart Institute (InCor), Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil

Abstract

Background Malignant or benign diseases can cause isolated intrathoracic lymphadenopathy (ITLN), a common dilemma in clinical practice.1 Our aim was to analyse differential diagnosis of isolated ITLN in patients undergoing EBUS-TBNA and to calculate its sensitivity, specificity, positive predictive value (PPV) and predictive negative value (PNV).

Methods Retrospective study of patients with isolated ITLN undergoing EBUS-TBNA for diagnosis, from August 2011 to April 2017. For non-specified granuloma, reactive or inconclusive LN by EBUS-TBNA, a definite diagnosis was established by other procedures or clinical, laboratorial and radiological follow-up of 18 months. Exclusion criteria: suspicion or history of cancer.

Results We included 58 patients with mean age of 53 years (SD=15), mostly female (56.9%). EBUS-TBNA diagnosed 21 (36.2%) granulomatosis, 15 (25.9%) reactive LN, 8 (13.8%) cancer and 4 (6.9%) other diseases. 17.2% (n=10) of cases were inconclusive by EBUS-TBNA and definite diagnosis was established by surgical biopsy (60%) and other bronchoscopic methods (40%). In granulomatous disease, EBUS-TBNA diagnosed mycobacteriosis in 23.8%, sarcoidosis in 4.7%, silicosis in 4.7% and 66.6% remained as non-specified granuloma. The definite diagnosis of these granulomas was made by other bronchoscopic methods (42.9%), surgical methods (21.4%) and clinical follow-up (35.7%). 73.3% of reactive LN (n=11) were subsequently confirmed by follow-up (91%) or mediastinoscopy (9%). 26.7% (n=4) of reactive LN resulted in tuberculosis (6.7%), sarcoidosis (6.7%) and neoplasia (13.3%) by others procedures or follow-up. EBUS-TBNA showed a sensitivity of 74%, 66.7% and 92.3%, specificity of 94.7%, 100% and 91.1%, PPV of 95.2%, 100% and 75%, and PNV of 84.4%, 92.6% and 97.6% for granulomatosis, neoplasia and reactive LN diagnosis, respectively.

Conclusions Isolated ITLN were mostly benign and reactive LN was the second most frequent cause. More than 70% of reactive LN by EBUS-TBNA were confirmed and the majority had no need for more invasive procedures. EBUS-TBNA showed to be a useful diagnostic procedure in isolated ITLN, with a great PPV, and its accuracy can be optimised by follow-up or minimal invasive procedures.

Reference

  1. Yang H, et al. Utility of endobronchial ultrasound-guided transbronchial needle aspiration in diagnosing non-specific inflammatory intrathorcacic lymphadenitis. Clin Respir J2016, Nov 7.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.